PPARGC1A and hepatocellular carcinoma: Using the inverse-variance-weighted (IVW) estimator, EHD4 displayed a significant positive association with HCC (Figure 4A–C), whereas PPARGC1A was inversely associated with disease susceptibility (Figure 4D–F).